News + Filings Transactions
|
Naughton Gail K
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/08/2023 | CEL SCI CORP | CVM | Grant | Options | 85k | $1.36 | $115.6k | | 08/08/2023 |
| 07/17/2023 | TherapeuticsMD, Inc. | TXMD | Grant | Restricted Stock Unit | 8.5k | $0.00 | $0 | | 07/17/2023 |
| 12/07/2022 | TherapeuticsMD, Inc. | TXMD | Sale | Common Stock | 3.9k | $5.26 | $20.6k | | 12/07/2022 |
| 09/29/2022 | TherapeuticsMD, Inc. | TXMD | Grant | Restricted Stock Units | 5k | $0.00 | $0 | | 09/29/2022 |
| 08/18/2022 | TherapeuticsMD, Inc. | TXMD | Exercise | Restricted Stock Units | 2k | $0.00 | $0 | | 08/18/2022 |
| 08/10/2021 | TherapeuticsMD, Inc. | TXMD | Exercise | Restricted Stock Units | 96.9k | $0.00 | $0 | | 08/10/2021 |
| 07/01/2021 | TherapeuticsMD, Inc. | TXMD | Grant | Restricted Stock Units | 99.2k | $0.00 | $0 | | 07/01/2021 |
| 01/13/2021 | Histogen Inc. | CNAT | Grant | Stock Option (right to buy) | 95k | $0.97 | $92.2k | | 01/13/2021 |
| 06/18/2020 | TherapeuticsMD, Inc. | TXMD | Grant | Restricted Stock Units | 96.9k | $0.00 | $0 | | 06/18/2020 |
| 05/26/2020 | Histogen Inc. | CNAT | Other (acquisition) | Common Stock | 426.5k | $0.00 | $0 | See Footnote | 05/26/2020 |
| 12/29/2017 | BARD C R INC /NJ/ | BCR | Disposition | Common Stock | 1.9k | $0.00 | $0 | | 12/29/2017 |
| 12/29/2017 | BARD C R INC /NJ/ | BCR | Disposition | | 9.5k | $0.00 | $0 | | 12/29/2017 |
| 12/04/2017 | BARD C R INC /NJ/ | BCR | Grant | | 245 | $0.00 | $0 | | 12/04/2017 |
| 12/04/2017 | BARD C R INC /NJ/ | BCR | Grant | Common Stock | 298 | $0.00 | $0 | | 12/04/2017 |
| 11/28/2017 | PLUS THERAPEUTICS, INC. | CYTX | Exercise (in-the-money or at-the-money) | Warrants (Right to Buy) | 1.8k | $0.33 | $599.9 | | 11/28/2017 |
| 11/28/2017 | PLUS THERAPEUTICS, INC. | CYTX | Exercise (in-the-money or at-the-money) | Series B Preferred Stock | 1 | $0.33 | $0.3 | | 11/28/2017 |
| 11/28/2017 | PLUS THERAPEUTICS, INC. | CYTX | Exercise (in-the-money or at-the-money) | Subscription Rights (Right to Buy) | 1 | $1,000.00 | $1000 | | 11/28/2017 |
| 01/31/2017 | BARD C R INC /NJ/ | BCR | Sale | Common Stock | 367 | $236.22 | $86.7k | | 01/31/2017 |
| 01/26/2017 | PLUS THERAPEUTICS, INC. | CYTX | Grant | Non-Qualified Stock Option (right to buy) | 25k | $0.00 | $0 | | 01/26/2017 |
| 06/14/2016 | PLUS THERAPEUTICS, INC. | CYTX | Purchase | Common Stock | 1000 | $2.10 | $2.1k | | 06/14/2016 |
| 02/02/2016 | BARD C R INC /NJ/ | BCR | Sale | Common Stock | 584 | $187.88 | $109.7k | | 02/02/2016 |
| 12/09/2015 | BARD C R INC /NJ/ | BCR | Grant | Common Stock | 536 | $0.00 | $0 | | 12/09/2015 |
| 12/09/2015 | BARD C R INC /NJ/ | BCR | Grant | | 442 | $0.00 | $0 | | 12/09/2015 |
| 10/27/2015 | BARD C R INC /NJ/ | BCR | Sale | Common Stock | 2.5k | $181.99 | $447.3k | | 10/27/2015 |
| 10/27/2015 | BARD C R INC /NJ/ | BCR | Exercise | | 1.2k | $88.76 | $106.5k | | 10/27/2015 |
| 10/27/2015 | BARD C R INC /NJ/ | BCR | Exercise | | 800 | $81.70 | $65.4k | | 10/27/2015 |
| 04/28/2015 | BARD C R INC /NJ/ | BCR | Sale | Common Stock | 763 | $170.61 | $130.2k | | 04/28/2015 |
| 02/13/2015 | PLUS THERAPEUTICS, INC. | CYTX | Grant | Incentive Stock Option (Right to Buy) | 25k | $0.47 | $11.8k | | 02/13/2015 |
| 12/10/2014 | BARD C R INC /NJ/ | BCR | Grant | Common Stock | 605 | $0.00 | $0 | | 12/10/2014 |
| 12/10/2014 | BARD C R INC /NJ/ | BCR | Grant | | 413 | $0.00 | $0 | | 12/10/2014 |
| 10/27/2014 | BARD C R INC /NJ/ | BCR | Sale | Common Stock | 400 | $158.70 | $63.5k | | 10/27/2014 |
| 07/01/2014 | PLUS THERAPEUTICS, INC. | CYTX | Grant | | 21k | $0.00 | $0 | | 07/01/2014 |
| 07/01/2014 | PLUS THERAPEUTICS, INC. | CYTX | Grant | | 21k | $2.40 | $50.4k | | 07/01/2014 |
| 02/19/2014 | BARD C R INC /NJ/ | BCR | Sale | Common Stock | 800 | $140.63 | $112.5k | | 02/19/2014 |
| 12/11/2013 | BARD C R INC /NJ/ | BCR | Grant | Common Stock | 367 | $0.00 | $0 | | 12/11/2013 |
|
|